Composition for ameliorating peripheral sensory neuropathy

Abstract

A composition for ameliorating peripheral sensory neuropathy, which is characterized by including a Lentinus edodes mycelium extract, ameliorates symptoms induced by the drug such as the anticancer drug, including numbness of extremities, a pain in extremities, a reduction in deep tendon reflection, a reduction in muscle force, allodynia, hyperalgesia, impaired finger fine movement, impaired walking, stumbling, falling, impaired flexion (being difficult or impossible to sit on one's heels, sit cross-legged, sit with one's legs out to one side, sit on a chair, or the like), or paralysis of extremities.

1 . A composition for ameliorating peripheral sensory neuropathy comprising a Lentinus edodes mycelium extract. 
     
     
         2 . The composition for ameliorating peripheral sensory neuropathy according to  claim 1 , wherein the peripheral sensory neuropathy is induced after administration of an anticancer drug. 
     
     
         3 . The composition for ameliorating peripheral sensory neuropathy according to  claim 2 , wherein the anticancer drug is at least one selected from a DNA replication inhibitor, a microtubule-stabilizing agent, a microtubule polymerization inhibitor, and a proteasome inhibitor. 
     
     
         4 . The composition for ameliorating peripheral sensory neuropathy according to  claim 2 , wherein the anticancer drug is a platinum-based anticancer drug. 
     
     
         5 . A medical composition for ameliorating peripheral sensory neuropathy comprising a Lentinus edodes mycelium extract. 
     
     
         6 . A processed food comprising a Lentinus edodes mycelium extract, wherein the processed food ameliorates peripheral sensory neuropathy. 
     
     
         7 . The composition for ameliorating peripheral sensory neuropathy according to  claim 3 , wherein the anticancer drug is a platinum-based anticancer drug.